Concepedia

Daniel Meibom

DM

Statistics

Publications

12

Citations

601

H-Index

12

Active since

1996

Affiliations

Bayer (Germany)(Current)

Uppsala University

University of Wuppertal

Daniel Meibom is an author at Bayer (Germany) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

1996–2025

12

Publications

12

Solution Conformations Shed Light on PROTAC Cell Permeability

Yoseph Atilaw, Vasanthanathan Poongavanam, Caroline Svensson Nilsson et al. · ACS Medicinal Chemistry Letters · 2020 · 172 citations · Full text

Linker-Dependent Folding Rationalizes PROTAC Cell Permeability

Vasanthanathan Poongavanam, Yoseph Atilaw, Stephan Siegel et al. · Journal of Medicinal Chemistry · 2022 · 106 citations · Full text

Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85‐8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases

Franz von Nussbaum, Volkhart M.‐J. Li, Swen Allerheiligen et al. · ChemMedChem · 2015 · 66 citations · Full text

Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A<sub>1</sub> Receptor Agonist for the Chronic Treatment of Heart Diseases

Daniel Meibom, Barbara Albrecht‐Küpper, Nicole Diedrichs et al. · ChemMedChem · 2017 · 54 citations

Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY‐8040 in a Pulmonary Arterial Hypertension Rat Model

Franz von Nussbaum, Volkhart M. Li, Daniel Meibom et al. · ChemMedChem · 2015 · 50 citations

, , +23

1–5 of 12